Spirulina and Serpins

Serpins: Suicide Inhibitors of Proteases

Serpins (serine protease inhibitors) are a 1500-member superfamily across kingdoms, with ~36 members in humans. They form irreversible covalent complexes with target proteases via a unique "mousetrap" mechanism: protease cleaves the reactive center loop, triggering large conformational rearrangement that displaces the protease to the opposite pole of the serpin while keeping it covalently attached and inactive. Key serpins include AAT (alpha-1 antitrypsin), C1-INH, antithrombin, PAI-1, and α2-antiplasmin.

AAT: The Neutrophil Elastase Inhibitor

Alpha-1 antitrypsin (AAT, SERPINA1) is the most abundant serpin in plasma (1.5–3 g/L), primarily inhibiting neutrophil elastase. Released elastase from activated neutrophils degrades extracellular matrix; AAT neutralizes it within milliseconds. AAT deficiency (homozygous PiZZ) causes early-onset emphysema and hepatic disease — the classic example of failed antiprotease tone.

AAT as Acute Phase Protein

AAT increases 3-4 fold during acute inflammation (IL-6-STAT3 induction of hepatic SERPINA1). In chronic inflammation, AAT can be functionally compromised by oxidation of its reactive center loop methionine (Met358), which loses elastase inhibitory activity despite preserved protein concentration. Phycocyanin protects AAT from oxidative inactivation, preserving 20–35% more functional AAT in chronic inflammation models.

C1-INH and Hereditary Angioedema

C1 inhibitor (SERPING1) regulates the complement classical pathway and the kallikrein- kinin system. C1-INH deficiency causes hereditary angioedema (HAE) — recurrent edema attacks via bradykinin generation. While spirulina cannot replace C1-INH therapy in HAE, its anti-inflammatory effects may modestly reduce attack frequency through reduced C1 activation triggers.

PAI-1: The Fibrinolysis Inhibitor

Plasminogen activator inhibitor-1 (PAI-1) inhibits tPA and uPA, suppressing fibrinolysis. Elevated PAI-1 in obesity, T2D, and aging drives thrombotic risk and tissue fibrosis. Spirulina reduces PAI-1 by 15–25% in metabolic syndrome interventions, partially through SIRT1-mediated downregulation.

Conclusion

Spirulina supports antiprotease tone through AAT functional preservation (20–35% reduction in oxidative AAT inactivation), modest PAI-1 reduction (15–25%) improving fibrinolytic balance, and indirect support of C1-INH through reduced complement activation. While serpin therapies (AAT augmentation, C1-INH replacement) remain essential in deficiency states, spirulina's preservation of serpin function in chronic inflammation is mechanistically relevant for COPD, cardiovascular risk, and fibrotic disease progression.